1. A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN'S DISEASE WITH ADALIMUMAB-BASED TREATMENT: ECONOMIC EVALUATION OF CALM TRIAL FROM CANADIAN PERSPECTIVE. (15th March 2019) Authors: Panaccione, R; Colombel, J; Bossuyt, P; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, A; Reinisch, W; Johnson, S; Buessing, M; Neimark, E; Petersson, J; Robinson, A M; Thakkar, R B; Lee, W; Skup, M; D'Haens, G Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP065 Long-term cost-effectiveness of tight control for Crohn's disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial. (16th January 2018) Authors: Panaccione, R; Colombel, J -F; Bossuyt, P; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, A; Reinisch, W; Johnson, S; Buessing, M; Neimark, E; Petersson, J; Robinson, A M; Thakkar, R B; Lee, W -J; Skup, M; D'Haens, G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP071 Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn's disease: data from CALM. (16th January 2018) Authors: Panaccione, R; Colombel, J -F; Bossuyt, P; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, A; Reinisch, W; Neimark, E; Petersson, J; Robinson, A M; Thakkar, R B; Chen, N; Skup, M; Lee, W -J; D'Haens, G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP74 Initial Clearance of infliximab is a predictor for the time of formation of anti-drug antibodies. (27th May 2021) Authors: Kutschera, M; Primas, C; Reinisch, S; Novacek, G; Kim, S H; Lee, S H; Lee, J H; Reinisch, W; Mould, D R Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Issue 4 (11th March 2004) Authors: Miehsler, W; Reinisch, W; Valic, E; Osterode, W; Tillinger, W; Feichtenschlager, T; Grisar, J; Machold, K; Scholz, S; Vogelsang, H; Novacek, G Journal: Gut Issue: Volume 53:Issue 4(2004) Page Start: 542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM. (25th January 2019) Authors: Yzet, C; Ungaro, R; Bossuyt, P; Baert, F; Vanasek, T; D'Haens, G; Joustra, V; Panaccione, R; Novacek, G; Armuzzi, A; Golovchenko, O; Prymak, O; Goldis, A; Travis, S; Hébuterne, X; Ferrante, M; Rogler, G; Fumery, M; Danese, S; Rydzewska, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P151 Risk factors for first intestinal surgery in Crohn's disease. (25th January 2019) Authors: Novacek, G; Reinisch, W; Reinisch, S; Primas, C; Eigner, W; Vogelsang, H; Dejaco, C; Kazemi-Shirazi, L; Niapir, M; Mekhail, P; Pedarnig, N; Angermann, H; Waldhör, T Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P264 Prevalence and predictors of stoma formation and restoration of intestinal continuity in patients with Crohn's disease in a tertiary referral hospital: A retrospective explorative study. (21st January 2022) Authors: Primas, C; Waldhör, T; Kozbial, K; Dawoud, C; Riss, S; Reinisch, W; Niapri, M; Kutschera, M; Kazemi-Shirazi, L; Reinisch, S; Dabsch, S; Pedarnig, N; Angermann, H; Novacek, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P279 Potential of managed care programmes for patients with inflammatory bowel diseases – results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASEIBD study). (27th May 2021) Authors: Bokemeyer, B; Kaiser, C; Primas, C; Novacek, G; Biedermann, L; Seibold, F; Tappe, U; Bettenworth, D; Graw, J; Hartmann, P; Plachta-Danielzik, S; Schultz, C Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P331 Real-world assessment of biological treatment of inflammatory bowel disease at an Austrian Referral Centre: the ULTIMATE study. (25th January 2019) Authors: Gröchenig, H P; Walter, E; Redl, A; Bresztowanszky, M; Steidl, K; Siebert, F; Novacek, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗